How are CYP1A2 and Abnehmen related?

CYP1A2 encodes a cytochrome P450 enzyme that primarily metabolizes caffeine. Genetic variants (e.g., rs762551, also called CYP1A2*1F) classify individuals as 'fast' (AA) or 'slow' (CC) caffeine metabolizers. Some research suggests that caffeine can increase energy expenditure and fat oxidation, and that fast metabolizers may experience a slightly greater thermogenic effect. However, the link to actual weight loss (Abnehmen) is weak and inconsistent. Most studies are observational or small intervention trials; large randomized controlled trials are lacking. The effect size is small and easily overshadowed by diet, physical activity, sleep, and overall lifestyle. Direct-to-consumer DNA tests often overstate the clinical relevance. Therefore, CYP1A2 genotype alone is not a reliable predictor of weight loss success. A comprehensive approach remains essential. Caveat: CYP1A2 also metabolizes certain drugs (e.g., clozapine, theophylline); genotype-informed dosing may be relevant in clinical settings, but for weight management the evidence is insufficient for strong recommendations.